Activation of paracrine growth factors by heparan sulphate induced by glucocorticoid in A549 lung carcinoma cells
1997

Glucocorticoid-Induced Heparan Sulphate in Lung Cancer Cells

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): N Yevdokimova, RI Freshney

Primary Institution: University of Glasgow

Hypothesis

Does glucocorticoid treatment induce the production of heparan sulphate that regulates growth factors in A549 lung carcinoma cells?

Conclusion

Heparan sulphate produced in response to glucocorticoid treatment enhances the activity of growth factors in lung carcinoma cells.

Supporting Evidence

  • Dexamethasone treatment significantly increased alkaline phosphatase activity in A549 cells.
  • Heparan sulphate was identified as a key factor in the regulation of growth factor activity.
  • Conditioned medium from fibroblasts enhanced the effects of glucocorticoids on A549 cells.

Takeaway

When scientists treated lung cancer cells with a medicine called glucocorticoid, it helped the cells make a special sugar that helps them grow and respond to other signals.

Methodology

A549 cells were treated with dexamethasone and analyzed for alkaline phosphatase activity and glycosaminoglycan production.

Limitations

The study primarily focused on a single cell line and may not be generalizable to other types of cells.

Statistical Information

P-Value

0.0014

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication